Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification

scientific article published on 01 March 2020

Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JNCI/DJZ113
P932PMC publication ID7073933
P698PubMed publication ID31165158

P50authorMichael E JonesQ92480941
Penny CoulsonQ114337675
Parichoy Pal ChoudhuryQ117276789
Montserrat García-ClosasQ28356305
Minouk J SchoemakerQ37371896
Mark N BrookQ57517906
Anthony SwerdlowQ60492223
Nick OrrQ78318000
Gail MitchellQ87048867
Amber WilcoxQ89547723
P2093author name stringThomas Ahearn
Nilanjan Chatterjee
Yan Zhang
P2860cites workPerformance of BCRAT in high-risk patients with breast cancerQ92510711
Performance of BCRAT in high-risk patients with breast cancer - Authors' replyQ92510717
Generalized meta-analysis for multiple regression models across studies with disparate covariate informationQ92711008
The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control studyQ27644636
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.Q30238753
Developing and evaluating polygenic risk prediction models for stratified disease preventionQ30251440
External validation of multivariable prediction models: a systematic review of methodological conduct and reportingQ30577024
Constrained Maximum Likelihood Estimation for Model Calibration Using Summary-level Information from External Big Data SourcesQ31124729
Validation of the Gail et al. model of breast cancer risk prediction and implications for chemopreventionQ32133889
An assessment of existing models for individualized breast cancer risk estimation in a screening program in SpainQ33643562
Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performanceQ33739374
Effect of changing breast cancer incidence rates on the calibration of the Gail modelQ33897605
Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studiesQ33940145
Assessment of clinical validity of a breast cancer risk model combining genetic and clinical informationQ34267477
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancerQ34736112
Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I.Q35000324
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programmeQ35441054
The contributions of breast density and common genetic variation to breast cancer riskQ36137764
SNPs and breast cancer risk prediction for African American and Hispanic womenQ36322904
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohortQ36336239
Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysisQ36507079
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Assessing the performance of prediction models: a framework for traditional and novel measuresQ36617895
Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family RegistryQ36619329
Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort studyQ36649796
Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studiesQ37059182
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive modelQ37172219
Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk modelQ37246495
Evaluating breast cancer risk projections for Hispanic womenQ37307773
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening StrategiesQ37364628
Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening OutcomesQ37444608
A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performanceQ37950847
Risk prediction models of breast cancer: a systematic review of model performancesQ37955078
Comparison of approaches for incorporating new information into existing risk prediction modelsQ39108831
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.Q39263736
Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk WomenQ39394075
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United StatesQ39734134
Breast cancer risk prediction using a clinical risk model and polygenic risk scoreQ40605693
Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.Q45956105
Association analysis identifies 65 new breast cancer risk loci.Q45979098
Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.Q45990033
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerQ46103372
Predicting risk of breast cancer in postmenopausal women by hormone receptor statusQ46901894
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumQ47190168
Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.Q48717652
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.Q49964811
Validation of the Gail et al. model for predicting individual breast cancer risk.Q50603613
Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.Q51933968
A breast cancer prediction model incorporating familial and personal risk factors.Q52000310
Gail Model for Prediction of Absolute Risk of Invasive Breast Cancer: Independent Evaluation in the Florence–European Prospective Investigation Into Cancer and Nutrition CohortQ56836342
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table ModelQ57177092
Decision curve analysis: a technical noteQ58804823
Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian womenQ60942791
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesQ62583133
Reproductive Factors and Mammographic Density: Associations Among 24,840 Women and Comparison of Studies Using Digitized Film-Screen Mammography and Full-Field Digital MammographyQ64113573
10-year performance of four models of breast cancer risk: a validation studyQ64115284
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer riskQ64279327
Projecting individualized probabilities of developing breast cancer for white females who are being examined annuallyQ69396132
Polygenic susceptibility to breast cancer and implications for preventionQ78029012
Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast DensityQ88282837
The personal and clinical utility of polygenic risk scoresQ88778863
iCARE: An R package to build, validate and apply absolute risk modelsQ89547730
Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traitsQ90929499
Assessment of breast cancer risk: which tools to use?Q91866775
P433issue3
P304page(s)278-285
P577publication date2020-03-01
P1433published inJournal of the National Cancer InstituteQ400279
P1476titleComparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification
P478volume112

Reverse relations

cites work (P2860)
Q91388567Application of convolutional neural networks to breast biopsies to delineate tissue correlates of mammographic breast density
Q90300115Choosing Breast Cancer Risk Models: Importance of Independent Validation
Q96577447Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data
Q90814829Electronic health records and polygenic risk scores for predicting disease risk
Q90300125Performance of breast cancer risk assessment models in a large mammography cohort
Q96577047Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Q91788154Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers
Q98611548Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Q89511306Using Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment: A Novel Risk Factor Based on the Quantitative Tissue Property of Sound Speed

Search more.